These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal. Johnson AP; Livermore DM Lancet; 1999 Dec; 354(9195):2012-3. PubMed ID: 10636359 [No Abstract] [Full Text] [Related]
8. Linezolid for the treatment of infections caused by Gram-positive pathogens in China. Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341 [TBL] [Abstract][Full Text] [Related]
9. Treatment of vancomycin-resistant Enterococcus faecium infections. Lai KK Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301 [TBL] [Abstract][Full Text] [Related]
14. [Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials]. Lin ZQ; Huang YL; Huang P; Chen Q Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):900-6. PubMed ID: 21211409 [TBL] [Abstract][Full Text] [Related]
15. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases. Sgarabotto D; Cusinato R; Narne E; Scano F; Zignol M; Gambino A; Cattelan A; Meneghetti F; Cadrobbi P Scand J Infect Dis; 2002; 34(2):122-6. PubMed ID: 11928842 [TBL] [Abstract][Full Text] [Related]
17. Establishing the role of tigecycline in an era of antimicrobial resistance. Schafer JJ; Goff DA Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395 [TBL] [Abstract][Full Text] [Related]
18. Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections. Wilson SE Surg Infect (Larchmt); 2001; 2(1):25-35. PubMed ID: 12594878 [TBL] [Abstract][Full Text] [Related]
19. [GEIPC-SEIMC (Study Group for Infections in the Critically Ill Patient of the Spanish Society for Infectious Diseases and Clinical Microbiology) and GTEI-SEMICYUC ( Working Group on Infectious Diseases of the Spanish Society of Intensive Medicine, Critical Care, and Coronary Units) recommendations for antibiotic treatment of gram-positive cocci infections in the critical patient]. Astigarraga PM; Montero JG; Cerrato SG; Colomo OR; Martínez MP; Crespo RZ; García-Paredes PM; Cerdá EC; Lerma FA Enferm Infecc Microbiol Clin; 2007; 25(7):446-66. PubMed ID: 17692213 [TBL] [Abstract][Full Text] [Related]
20. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]